Full Press Release Details
RALEIGH, N.C., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation’s largest outpatient imaging providers, today announced the opening of three new outpatient imaging centers in North Carolina, South Carolina, and Texas. The new locations reflect Lumexa Imaging’s disciplined approach to expanding in attractive markets, building greater density across its existing network, and supporting long-term, sustainable growth.
“Our continued de novo expansion reflects the strength of our operating platform and our ability to execute against our long-term growth strategy,” said Caitlin Zulla, Chief Executive Officer of Lumexa Imaging. “We are intentional about where we invest, prioritizing markets where demand for outpatient imaging is strong and where we can build meaningful scale. As our newer locations mature and contribute to our performance, these investments will support sustainable growth and position us to create long-term value for our patients, providers, and shareholders.”
Lumexa Imaging’s de novo strategy prioritizes markets with attractive demographic trends, growing demand for outpatient imaging, and opportunities to strengthen its existing network. By expanding its presence in established markets, the company seeks to build on its operating infrastructure, physician relationships, and commercial capabilities to support the successful ramp-up of new centers. With these new locations, the Company has added 5 de novo outpatient centers to its national footprint this year. In total, Lumexa expects to open 8-10 new de novo centers in 2026.
Lumexa Imaging benefits from durable long-term tailwinds, including an aging population, the expansion of imaging-driven treatment pathways, rising preventive screening rates, and a sustained shift from hospital-based to outpatient imaging within a fragmented, capacity-constrained industry.
Lumexa Imaging’s continued investment in de novo development builds on the performance of its existing centers. The company remains focused on disciplined capital deployment, targeting attractive long-term returns from its investments in new centers. These investments position Lumexa to expand its outpatient imaging network while supporting its long-term growth objectives.
About Lumexa Imaging
Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team members and approximately 190 outpatient imaging centers, our team conducted approximately 4 million outpatient procedures system-wide in 2025. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release may be forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “goal,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” or “will,” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements in this release include, but are not limited to, statements regarding our expectations, goals, strategies and long-term objectives, including our ability to drive future growth, execute on our de novo development strategy, capitalize on market trends and demand, and realize anticipated returns on our capital deployment. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including but not limited to those risk factors identified in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of our Annual Report on Form 10-K for the year ended December 31, 2025 and our later dated Quarterly Reports on Form 10-Q, each as filed with the Securities and Exchange Commission. The forward-looking statements in this press release are based on information available to us as of the date hereof, and we disclaim any obligations to update any forward-looking statements, except as required by law.